No Data
No Data
Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Most readers would already be aware that Protagonist Therapeutics' (NASDAQ:PTGX) stock increased significantly by 32% over the past three months. Given that stock prices are usually aligned with a
Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024
NEWARK, CA / ACCESSWIRE / July 22, 2024 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive
Nike, Kura Sushi Fall; Infinera, Protagonist Therapeutics Rise, Friday, 6/28/2024
Market-Moving News for June 28th
PTGX: 11% | Protagonist Therapeutics To Join S&P SmallCap 600, Effective Prior To Opening Of Trading On July 3DJT: 16% | Trump Media & Technology Group shares are trading higher following Thursday's p
Express News | Protagonist Therapeutics Shares Are Trading Higher After It Was Announced the Company Will Join the S&P SmallCap 600
Protagonist Therapeutics Set to Join S&P SmallCap 600